Poseida Therapeutics (PSTX) had the highest return between November 25, 2024 and December 3, 2024 by a small-cap US stock, returning 232%.
| ASSET | DATE | % RETURN |
|---|---|---|
Poseida Therapeutics (PSTX) | 11/25/2024 - 12/3/2024 | 232.03% |
ZJK Industrial (ZJK) | 11/25/2024 - 12/3/2024 | 200.02% |
Microvast (MVST) | 11/25/2024 - 12/3/2024 | 110.86% |
Renovaro Biosciences (RENB) | 11/25/2024 - 12/3/2024 | 106.6% |
Innoviz Technologies (INVZW) | 11/25/2024 - 12/3/2024 | 70% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 11/25/2024 - 12/3/2024 | 64.61% |
Lexinfintech (LX) | 11/25/2024 - 12/3/2024 | 59.71% |
Porch (PRCH) | 11/25/2024 - 12/3/2024 | 58.92% |
Logistic Properties of the Americas (LPA) | 11/25/2024 - 12/3/2024 | 50.77% |
Embecta (EMBC) | 11/25/2024 - 12/3/2024 | 46.98% |
Verve Therapeutics (VERV) | 11/25/2024 - 12/3/2024 | 41.33% |
Satellogic V (SATL) | 11/25/2024 - 12/3/2024 | 40% |
Dana (DAN) | 11/25/2024 - 12/3/2024 | 39.88% |
Evolv Technologies (EVLV) | 11/25/2024 - 12/3/2024 | 36.74% |
Mercurity Fintech Holding Inc ADR (MFH) | 11/25/2024 - 12/3/2024 | 36.36% |
Blade Air Mobility (BLDEW) | 11/25/2024 - 12/3/2024 | 31.43% |
Ginkgo Bioworks (DNA) | 11/25/2024 - 12/3/2024 | 31.31% |
Adaptive Biotechnologies (ADPT) | 11/25/2024 - 12/3/2024 | 30.98% |
Qudian (QD) | 11/25/2024 - 12/3/2024 | 30.34% |
Sleep Number (SNBR) | 11/25/2024 - 12/3/2024 | 30.14% |
POET Technologies (POET) | 11/25/2024 - 12/3/2024 | 29.13% |
Esperion Therapeutics (ESPR) | 11/25/2024 - 12/3/2024 | 28.97% |
Youdao (DAO) | 11/25/2024 - 12/3/2024 | 28.35% |
Vir Biotechnology (VIR) | 11/25/2024 - 12/3/2024 | 27.6% |
Neuropace (NPCE) | 11/25/2024 - 12/3/2024 | 26.91% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
